Atopic Dermatitis

Also known as: Atopic Eczema · Eczema (common usage) · Infantile or Childhood Eczema · Flexural Dermatitis · Atopic Neurodermatitis (older European usage)

Medicine

Definition

Atopic Dermatitis (AD), also called atopic eczema, is a chronic, relapsing inflammatory disorder of the skin characterized by intense itching (pruritus), dry and scaly eczematous lesions, and a fundamental defect in the epidermal barrier. The disease typically appears in infancy or early childhood, follows an intermittent course with flare-ups and remissions, and frequently coexists with other atopic conditions such as asthma and allergic rhinitis in what clinicians call the atopic triad. At the cellular level, AD involves both a weakened skin barrier — partly linked to reduced function of the filament-aggregating protein filaggrin — and immune dysregulation dominated by type 2 inflammation, which together allow irritants and allergens to penetrate the skin and sustain the itch-scratch cycle. (StatPearls, Wikipedia)

Atopic dermatitis is one of the most common skin diseases worldwide, affecting an estimated 15 to 20 percent of children and 1 to 3 percent of adults, with roughly 230 million people affected globally. It is likewise a leading reason for dermatologic consultation in the Philippines: an analysis of 744,673 consultations at Philippine Dermatological Society-accredited training institutions from 2007 to 2011 found that most patients with atopic dermatitis were young, with 65.1 percent aged 1 to 12 years and 24 percent infants under one year old, prompting Philippine experts to publish localized recommendations built on anti-inflammatory treatment, barrier repair, and basic skin care. (JDD, AAD, Wikipedia)

Identities

Source Type Identity
Wikipedia Atopic dermatitis
Wikidata Q268667
DBpedia Atopic_dermatitis
ProductOntology N/A
Wiktionary atopic dermatitis
Library of Congress Subject Headings (LCSH) Atopic dermatitis
MeSH Dermatitis, Atopic (D003876)
NCBI Taxonomy N/A
AGROVOC N/A
Google Scholar atopic dermatitis eczema skin barrier filaggrin Philippines
ConceptNet N/A
OpenCyc N/A

Also Known As

  • Atopic Eczema
  • Eczema (common usage)
  • Infantile or Childhood Eczema
  • Flexural Dermatitis
  • Atopic Neurodermatitis (older European usage)

Examples and Analogies

  • Brick wall with weak mortar: In atopic dermatitis the skin barrier behaves like a wall whose mortar — the lipid matrix of ceramides, cholesterol, and fatty acids described in the entry on the skin barrier — is deficient. Water escapes, irritants seep in, and the wall must be constantly patched with moisturizers.
  • Fault alarm analogy: The immune system of an AD patient is like an oversensitive building alarm that triggers at the slightest dust; harmless substances that intact skin would ignore provoke full inflammatory sirens — redness, itching, and swelling.
  • Concrete example — the infant with sore cheeks: A six-month-old in Quezon City develops red, weeping, itchy patches on the cheeks and the folds of the arms during the hot season; a pediatric dermatologist diagnoses atopic dermatitis and prescribes gentle bathing, a ceramide-containing moisturizer, and anti-inflammatory treatment, consistent with published Philippine expert guidance. (JDD)
  • Concrete example — the mosquito bite that darkens: Because most Filipino skin is melanin-rich, healed eczema patches often leave brown marks, a reaction explained in the entry on post-inflammatory hyperpigmentation, which itself often distresses patients as much as the original itch.

Usage Scenarios

1. Pediatric Consultation at a PDS-Acccredited Clinic

A mother brings her toddler with chronically itchy elbow and knee folds to a Philippine Dermatological Society-accredited dermatologist. The diagnosis of atopic dermatitis is explained as a long-term barrier and immune problem rather than an allergy to be outgrown overnight, and the family is walked through a maintenance plan of moisturizers, trigger avoidance, and medically supervised flare control. (PDS, JDD)

2. Building a Barrier-Repair Routine in a Tropical Climate

A young professional in Cebu with hand eczema aggravated by frequent hand-washing and office air-conditioning is advised to use soap-free cleansers, apply a ceramide-based moisturizer within minutes of bathing — echoing the barrier-lipid replacement strategy described in the entry on ceramides — and to moderate sweating triggers during commutes. (StatPearls)

3. Evaluating an Online “Eczema Cure” Cream

A consumer in Davao encounters a social-media seller promoting an unregistered herbal cream that promises overnight eczema clearance. Before purchasing, she checks the product through the FDA Philippines verification portal, guarding against unregistered creams that surveillance has found adulterated with mercury or potent steroids. (FDA Verification, FDA)

Strategies

  • Moisten and protect the barrier daily with fragrance-free, ceramide-containing moisturizers, since defective barrier lipids drive the dryness and cracking of atopic dermatitis. (AAD)
  • Keep baths or showers short and lukewarm, use mild soap-free cleansers, and apply moisturizer immediately afterward to lock in water. (AAD)
  • Identify and reduce personal triggers — sweat, harsh detergents, wool, stress, and known allergens — while avoiding overly restrictive elimination diets that a clinician has not sanctioned. (StatPearls)
  • Treat flares early under medical supervision with proven anti-inflammatory therapy rather than abandoning treatment at the first improvement, since undertreatment sustains the itch-scratch cycle. (JDD)
  • Interrupt scratching with cool compresses, nail trimming, and distraction, especially in children, because scratching both worsens inflammation and raises the risk of skin infection and post-inflammatory hyperpigmentation in Filipino skin.

Security and Safety Measures

  • Do not buy creams marketed as fast “eczema cures” from informal online sellers; the FDA Philippines has repeatedly warned against adulterated and unauthorized cosmetics detected through the ASEAN Post-Marketing Alert System, some containing mercury. (FDA)
  • Beware of hidden potent steroids in unregistered “herbal” or “whitening” creams; unsupervised long-term use can thin the skin and cause rebound flares, and mercury-containing products carry kidney and neurological risks documented by the World Health Organization. (FDA, WHO)
  • Verify every product through the FDA Philippines verification portal and confirm that the treating physician is a board-certified dermatologist traceable through the Philippine Dermatological Society. (FDA Verification, PDS)
  • Seek urgent care if eczema develops painful cracks, oozing, yellow crusting, or fever — signs of bacterial infection such as staphylococcal or herpetic superinfection that require prescription treatment. (StatPearls)

Historical Context

The concept of atopy — an inherited tendency toward hypersensitivity reactions — was coined by American allergists Arthur Coca and Robert Cooke in 1923, and the skin disease was consolidated under the name atopic dermatitis by Fred Wise and Marion Sulzberger in 1933. Twentieth-century research then shifted the model from a purely allergic disorder to a dual barrier-plus-immune disease, accelerated by the discovery that mutations in the filaggrin gene impair the epidermal barrier and sharply raise the risk of AD. (Wikipedia, StatPearls)

In the Philippines, atopic dermatitis gained an organized clinical footprint through the specialty training institutions accredited by the Philippine Dermatological Society, whose consultation records documented the disease’s predominance among infants and schoolchildren. In 2021, a panel of Philippine dermatologists published expert recommendations adapting global evidence to local practice — pairing anti-inflammatory treatment with barrier repair and basic skin care — an acknowledgment that management must fit Filipino skin, climate, and access constraints. (JDD, PDS)

Challenges and Controversies

Steroid Phobia and Undertreatment

Many Filipino caregivers fear topical corticosteroids because of viral anecdotes about skin thinning, leading to premature discontinuation, underdosing, and uncontrolled disease. Philippine and international guidance recognize this “steroid phobia” as a major barrier and stress education: correctly selected anti-inflammatory therapy used for the right duration is safer than chronically inflamed, infected skin, while the true hazards come from unsupervised and hidden steroids in unregistered products. (JDD, AAD)

Unregulated Products Marketed for Eczema and Sensitive Skin

A persistent regulatory challenge is the informal-market sale of creams that promise to clear eczema or whiten skin rapidly. The FDA Philippines has issued successive public-health warnings against adulterated and unauthorized cosmetics found to contain mercury or potent drugs, and the World Health Organization documents the continuing availability of mercury-laced skin lighteners despite international bans. Enforcement across e-commerce platforms remains difficult, making consumer verification through official portals essential. (FDA, WHO)

Related Topic

  • Skin Barrier
  • Ceramides
  • Epidermis
  • Eczema
  • Filaggrin
  • Melanin
  • Post-Inflammatory Hyperpigmentation
  • Philippine Dermatological Society

References

  1. Atopic dermatitis – Wikipedia
  2. Atopic Dermatitis – StatPearls
  3. The ABC Topical Management of Atopic Dermatitis in Philippines: Expert Recommendations – Journal of Drugs in Dermatology
  4. Atopic Dermatitis – American Academy of Dermatology
  5. Filaggrin – Wikipedia
  6. FDA Advisory No. 2023-0105 – Adulterated and Unauthorized Cosmetic Product (Momila Whitening Cream)
  7. Philippine Dermatological Society
  8. FDA Philippines Verification Portal
  9. Mercury in Skin Lightening Products – World Health Organization

Twenty Twenty-Five

Designed with WordPress